Drug Patents owned by Armstrong Pharms

1. List of Primatene Mist drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8367734 ARMSTRONG PHARMS Stable epinephrine suspension formulation with high inhalation delivery efficiency
Jan, 2026

(2 years from now)

Do you want to check out PRIMATENE MIST patents from before 2022?

Drugs and Companies using EPINEPHRINE ingredient

Market Authorisation Date: 07 November, 2018

Treatment: NA

Dosage: AEROSOL, METERED;INHALATION

More Information on Dosage

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic